Senhwa Biosciences: Funding, Investors & Team (Sep 2026)
Senhwa Biosciences identifies and develops innovative therapies that have the potential to fundamentally change the way patients are treated. Our central philosophy is to unearth validated targets or therapies that could significantly improve treatment, but have not yet been properly exploited. As a value-added development company, Senhwa aims to take innovative therapies that could impact the current standard of care and drive them through to clinical proof-of-concept.
Senhwa Biosciences has raised $15.8M across 1 funding round on record, the most recent an undisclosed round of $15.8M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Senhwa Biosciences Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Senhwa Biosciences Funding Rounds
Senhwa Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Senhwa Biosciences Funding Compared to Other Biotechnology Startups
Senhwa Biosciences' latest round of $15.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Senhwa Biosciences in Biotechnology and Hsintien
Companies Similar to Senhwa Biosciences
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…
Senhwa Biosciences Funding FAQs
What does Senhwa Biosciences do?
Senhwa Biosciences identifies and develops innovative therapies that have the potential to fundamentally change the way patients are treated. Our central philosophy is to unearth validated targets or therapies that could significantly improve treatment, but have not yet been properly exploited. As a value-added development company, Senhwa aims to take innovative therapies that could impact the current standard of care and drive them through to clinical proof-of-concept.
How much funding has Senhwa Biosciences raised?
Senhwa Biosciences has raised $15.8M across 1 round on record. The most recent is an undisclosed round of $15.8M announced in Apr 2026.
When did Senhwa Biosciences last raise funding?
Senhwa Biosciences' most recent funding round on record is an undisclosed round of $15.8M, announced in Apr 2026.
Who founded Senhwa Biosciences?
FundedIQ lists Taisen Soong (Founder) at Senhwa Biosciences.
Where is Senhwa Biosciences headquartered?
Senhwa Biosciences is based in Hsintien, T'ai-wan, Taiwan.
How many employees does Senhwa Biosciences have?
Senhwa Biosciences is in the 11-50 employee band.
How does Senhwa Biosciences' funding compare to other Biotechnology startups?
Senhwa Biosciences' latest round of $15.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Senhwa Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Senhwa Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.